drugset
drugset / Trial / NCT04500002

Isonicotinic Acid Hydrazide (INH) Pretreatment With Misoprostol Versus Misoprostol Alone in Missed Abortion

NCT04500002 ↗

Unknown 240 enrolled Aswan University Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The primary endpoint was the success rate of adjuvant isonicotinic acid hydrazide (INH) and misoprostol versus misoprostol alone for medical termination of first-trimester pregnancy.

Timeline

Start
2020-09-01
Primary completion
2021-06-30
Completion
2021-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Isonicotinic Acid Hydrazide Unknown 900 mg —
Background Misoprostol Other / unclassified 800 ug Intravenous

Indications

uterine inflammatory disease